Non-invasive, Real-time Anesthetic Drug-monitoring System (ADM)

Rambam Health Care Campus

Status: Unknown

Conditions: Anesthesia

Treatments: Device: CorrecDose Infrared Monitor

Study type: Observational

Funder types: Other

Identifiers

NCT02776020

0347-15 RBM

Details and patient eligibility

About

The aim of this study is to determine efficacy of the "CorrecDose" device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.

Enrollment: 30 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women who have signed Informed consent form
• Women undergoing Trans vaginal ovum retrieval (TVOR) for invitro fertilization (IVF) and will be sedated with propofol administered intravenos (IV)

Exclusion criteria

• Women with background diseases
• Women with chronic use of drug and medication
• Women with peripheral blood vessels problems
• Women with high blood pressure
• Women with body mass index (BMI) score over 35 or less than 18

Trial design

30 participants in 1 patient group

Propofol sedated patients

Description:

Women undergoing a short trans vaginal ovum retrieval (TVOR) will be sedated with propofol , and monitored non-invasively for changes in blood propofol concentration levels. Propofol dosages will be adapted according to patients vital signs and their reaction to noxious stimuli exerted during the trans vaginal ovum retrieval (TVOR) procedure, irrespective to the proposed study in which these participants undergo.Those changes of administered propofol dosages will be observed by the anesthetic drug monitor (ADM). Propfol is administered by the anesthesiologist in a routine manner and according to anesthesiologist discretion .

Treatment:

Device: CorrecDose Infrared Monitor